Loading
Vector Borne Infectious Diseases / Vaccines and Immunoinformatics Approaches · Journal article
Health Science Reports · August 1, 2026
Raises a question worth testing. It does not answer one.
This is a computational immunoinformatic design of a multi-epitope vaccine candidate against Anaplasma phagocytophilum using MSP-4 antigen, with no experimental or clinical validation. The construct was designed in silico and predicted to have favorable physicochemical properties and immunogenic potential, but the authors explicitly state that experimental validation is required before any meaningful assessment of efficacy is possible.
Computational immunoinformatic design study. Target pathogen: Anaplasma phagocytophilum; intended host protection in cattle and humans. No actual human or animal subjects enrolled.. Intervention: Multi-epitope vaccine construct targeting MSP-4 antigen (10 CD8+, 9 CD4+, 2 B-cell epitopes linked with adjuvant)..
Vaccine construct incorporates 10 CD8+, 9 CD4+, and 2 B-cell epitopes Predicted antigenicity of 0.84 with no allergenic reactions and solubility of 0.97 Construct weight 47.98 kDa with aliphatic index 98.33, instability index 29.94, and GRAVY 0.339
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This computational work cannot inform clinical or veterinary practice until empirical validation—in vitro immunogenicity, animal challenge studies, and ultimately clinical trials—has been completed. The predictions are useful only as a starting point for bench research.
Computational immunology design study with no experimental validation, animal testing, or clinical data; raises questions about vaccine candidate feasibility but does not answer them.
As stated by the source record.
Quoted from the source exactly as published.
This computational work cannot inform clinical or veterinary practice until empirical validation—in vitro immunogenicity, animal challenge studies, and ultimately clinical trials—has been completed. The predictions are useful only as a starting point for bench research.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
ABSTRACT Background and Aims Bovine anaplasmosis is an intracellular tick‐borne, non‐contagious disease caused by gram‐negative bacteria of the family Anaplasmataceae and order Rickettsia. Anaplasma phagocytophilum is the etiological agent for human granulocytic anaplasmosis associated with severe health implications in parts of Europe and the USA and tick‐borne fever in a broad host range, including cattle. Major surface protein 4 (MSP‐4) is highly conserved and recognized as an essential immunodominant protein on the bacterial membrane, playing a crucial role in host‐cell interaction. Despite the pathogenic and zoonotic implications of A. phagocytophilum, effective vaccines have not been developed. The present research aimed to develop multiple epitope‐based constructs targeting the pathogen, with the aid of computational immunology tools within a reverse vaccinology framework. Methods The development and design of a multiepitope vaccine construct targeting the major surface protein‐4 (MSP‐4) antigen were accomplished using an immunoinformatic approach. Results The vaccine design incorporated 10 CD8 +, 9 CD4 +, and 2 B‐cell epitopes, interlinked through AAK, GPGPG, and KK peptides to facilitate optimal presentation of efficient conformation. The EAAK linker facilitated the precise attachment of the immunostimulant adjuvant to the N‐terminal of the subunit vaccine, thereby augmenting its capacity to stimulate and boost the immunogenic efficacy of the vaccine. The construct demonstrated a high antigenicity (0.84), was free from allergenic reactions, exhibited excellent solubility (0.97), structurally stable during binding interactions, and an inducer of important cytokines such as IFN‐γ and interleukin 4. The vaccine construct weighs 47.98 kDa, with a calculated aliphatic index score (98.33), overall predicted instability index value (29.94), and a GRAVY value of 0.339, revealing favorable physicochemical properties that suggest its overall stability and hydrophobicity. Conclusion The vaccine construct induced sufficient humoral and cellular response during immune simulation. Analysis of the immunogen model further confirmed its potential to stimulate the immune system effectively against bovine A. phagocytophilum infection. However, further validation is required using experimental approaches.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.